Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/6746
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSYLVESTER, Richard-
dc.contributor.authorde Wit, R.-
dc.contributor.authorCollette, L.-
dc.contributor.authorde Mulder, P.H.M.-
dc.contributor.authorSleijfer, D.T.-
dc.contributor.authorten Bokkel Huinink, W.W.-
dc.contributor.authorKaye, S.B.-
dc.contributor.authorvan Oosterom, A.T.-
dc.contributor.authorBoven, E.-
dc.contributor.authorStoter, G.-
dc.date.accessioned2007-12-20T16:10:14Z-
dc.date.available2007-12-20T16:10:14Z-
dc.date.issued1998-
dc.identifier.citationThe British journal of cancer, 78, p.1350 - 1355-
dc.identifier.urihttp://hdl.handle.net/1942/6746-
dc.titleSerum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance-
dc.typeJournal Contribution-
dc.identifier.epage1355-
dc.identifier.spage1350-
dc.identifier.volume78-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcat-
item.contributorSYLVESTER, Richard-
item.contributorde Wit, R.-
item.contributorCollette, L.-
item.contributorde Mulder, P.H.M.-
item.contributorSleijfer, D.T.-
item.contributorten Bokkel Huinink, W.W.-
item.contributorKaye, S.B.-
item.contributorvan Oosterom, A.T.-
item.contributorBoven, E.-
item.contributorStoter, G.-
item.accessRightsClosed Access-
item.fullcitationSYLVESTER, Richard; de Wit, R.; Collette, L.; de Mulder, P.H.M.; Sleijfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E. & Stoter, G. (1998) Serum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance. In: The British journal of cancer, 78, p.1350 - 1355.-
item.fulltextNo Fulltext-
Appears in Collections:Research publications
Show simple item record

Page view(s)

32
checked on Nov 7, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.